TuHURA Biosciences (HURA) Invested Capital (2012 - 2023)
TuHURA Biosciences (HURA) posted quarterly Invested Capital of $298000.0 for Q2 2023, down 58.67% year-over-year from $721000.0 in Q2 2022, and up 65.56% quarter-over-quarter from $180000.0 in Q1 2023.
TuHURA Biosciences (HURA) Invested Capital (2012 - 2023) Analysis & Trends
TuHURA Biosciences' Invested Capital history runs 12 years deep, the most recent figure standing at $298000.0 for Q2 2023.
- In Q2 2023, Invested Capital fell 58.67% year-over-year to $298000.0; the TTM figure through Mar 2024 stood at $298000.0 (down 85.26% YoY), while the FY2023 annual figure was $298000.0, down 58.67% from the prior year.
- Invested Capital for Q2 2023 stood at $298000.0, up from $180000.0 in the prior quarter.
- The five-year high for Invested Capital was $721000.0 in Q2 2022, with the low at $113240.0 in Q1 2019.
- The 5-year median for Invested Capital is $449500.0 (2020), against an average of $416277.9.
- The sharpest annual moves came in 2020 and 2023: Invested Capital surged 161.55% in 2020, then sank 60.7% in 2023.
- TuHURA Biosciences' Invested Capital stood at $276674.0 in 2019, then rose by 4.6% to $289397.0 in 2020, then surged by 87.63% to $543000.0 in 2021, then grew by 0.92% to $548000.0 in 2022, then sank by 45.62% to $298000.0 in 2023.
- Business Quant data shows HURA's Invested Capital at $298000.0 in Q2 2023, $180000.0 in Q1 2023, and $548000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 298,000.00 |
| Mar 31, 2023 | 180,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 573,000.00 |
| Jun 30, 2022 | 721,000.00 |
| Mar 31, 2022 | 458,000.00 |
| Dec 31, 2021 | 543,000.00 |
| Sep 30, 2021 | 491,000.00 |
| Jun 30, 2021 | 561,000.00 |
| Mar 31, 2021 | 503,000.00 |
| Dec 31, 2020 | 289,397.00 |
| Sep 30, 2020 | 441,000.00 |
| Jun 30, 2020 | 664,000.00 |
| Mar 31, 2020 | 296,184.00 |
| Dec 31, 2019 | 276,674.00 |
| Sep 30, 2019 | 211,300.00 |
| Jun 30, 2019 | 325,208.00 |
| Mar 31, 2019 | 113,240.00 |
| Dec 31, 2018 | 152,325.00 |
| Sep 30, 2018 | 168,103.00 |